BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 214605)

  • 1. Feline leukemia virus envelope glycoprotein vaccine: preparation and evaluation of immunizing potency in guinea pig and cat.
    Salerno RA; Lehman ED; Larson VM; Hilleman MR
    J Natl Cancer Inst; 1978 Dec; 61(6):1487-93. PubMed ID: 214605
    [No Abstract]   [Full Text] [Related]  

  • 2. Infection and immunization of cats with the Kawakami-Theilen strain of feline leukemia virus.
    Salerno RA; Larson VM; Phelps AH; Hilleman MR
    Proc Soc Exp Biol Med; 1979 Jan; 160(1):18-23. PubMed ID: 217021
    [No Abstract]   [Full Text] [Related]  

  • 3. Subunit vaccines against exogenous retroviruses: overview and perspectives.
    Hunsmann G
    Cancer Res; 1985 Sep; 45(9 Suppl):4691s-4693s. PubMed ID: 2410114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies from healthy cats exposed to feline leukemia virus lyse feline lymphoma cells slowly with cat complement.
    Grant CK; DeBoer DJ; Essex M; Worley MB; Higgins J
    J Immunol; 1977 Aug; 119(2):401-6. PubMed ID: 196021
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection and evaluation of feline oncornavirus-induced cell surface antigen(s) shed from cells in vitro.
    Wolff LH; Mathes LE; Schaller JP; Hoover EA; Olsen RG
    Cancer Res; 1977 Nov; 37(11):4134-7. PubMed ID: 198129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of feline leukemia virus vaccines.
    Legendre AM
    J Am Vet Med Assoc; 1994 Jul; 205(1):28. PubMed ID: 7928542
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of antisera to oncornavirus glycoprotein (gp71) on infections of cats with feline leukemia virus.
    de Noronha F; Schäfer W; Essex M; Bolognesi DP
    Virology; 1978 Apr; 85(2):617-21. PubMed ID: 208242
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement and tumor antibody levels in cats, and changes associated with natural feline leukemia virus infection and malignant disease.
    Grant CK; Pickard DK; Ramaika C; Madewell BR; Essex M
    Cancer Res; 1979 Jan; 39(1):75-81. PubMed ID: 216484
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
    Osterhaus A; Weijer K; Uytdehaag F; Jarrett O; Sundquist B; Morein B
    J Immunol; 1985 Jul; 135(1):591-6. PubMed ID: 2987351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Feline leukemia: current status regarding prevention].
    Moennig V
    Tijdschr Diergeneeskd; 1986 Feb; 111(4):178-84. PubMed ID: 3006279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feline leukemia vaccine: efficacy, contents and probable mechanism.
    Mastro JM; Lewis MG; Mathes LE; Sharpee R; Tarr MJ; Olsen RG
    Vet Immunol Immunopathol; 1986 Mar; 11(3):205-13. PubMed ID: 3008410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating antibodies to the feline leukemia virus and FOCMA in cats.
    Lizonová A; Grófová M
    Neoplasma; 1983; 30(3):281-6. PubMed ID: 6306490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of suppressor cells in feline leukemia virus-associated immunosuppression.
    Langweiler M; Cockerell GL; deNoronha F
    Cancer Res; 1983 May; 43(5):1957-60. PubMed ID: 6299534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active immunization with feline leukemia virus envelope glycoprotein suppresses growth of virus-induced feline sarcoma.
    Hunsmann G; Pedersen NC; Theilen GH; Bayer H
    Med Microbiol Immunol; 1983; 171(4):233-41. PubMed ID: 6304480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a subunit feline leukemia virus vaccine in exotic cats.
    Citino SB
    J Am Vet Med Assoc; 1988 Apr; 192(7):957-9. PubMed ID: 2835347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a feline leukemia virus vaccine in a controlled natural transmission study.
    Lafrado LJ
    J Am Vet Med Assoc; 1994 Mar; 204(6):914-7. PubMed ID: 8188511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy studies of live- and killed-feline leukemia virus vaccines.
    Pedersen NC; Theilen GH; Werner LL
    Am J Vet Res; 1979 Aug; 40(8):1120-6. PubMed ID: 230767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
    Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
    J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feline leukemia virus infection in a captive cheetah and the clinical and antibody response of six captive cheetahs to vaccination with a subunit feline leukemia virus vaccine.
    Briggs MB; Ott RL
    J Am Vet Med Assoc; 1986 Nov; 189(9):1197-9. PubMed ID: 2851578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.